K22.4 is dyskinesia of the esophagus, the motility code for achalasia, diffuse spasm, or nutcracker esophagus
Coverage will vary by plan, with many insurers likely requiring documentation of prior lifestyle intervention or failure on existing GLP-1 medications first
This issue should be evaluated separately from the gastrointestinal injury claims centralized in MDL No
Most BCBS affiliates require the following documentation for Zepbound prior authorization: a current BMI measurement showing 30 (or 27 with documented comorbidity), evidence of a structured weight management program lasting at least 3-6 months (diet, exercise, behavioral counseling), documentation that the patient has not responded adequately to lifestyle interventions alone, and relevant lab work including A1C levels if type 2 diabetes is a listed comorbidity
Throughout the first week and beyond, Troy Watson provides continuous support, offering tailored advice on nutrition, exercise, and lifestyle changes to complement the effects of semaglutide GLP-1
A quality provider will offer continuous support to manage side effects, adjust your dosage (a process called titration), and provide guidance on the crucial lifestyle factors like nutrition and exercise that make the medication so much more effective